Comment on article “Diagnostic rentability of close pleural biopsy: Tru-cut vs. Cope”

Authors

  • René Agustín Flores-Franco <p>Instituto Mexicano del Seguro Social, Hospital General Regional de Zona No. 1, Departamento de Medicina Interna. Chihuahua, Chihuahua</p>
  • Ernesto Ramos-Martínez <p>Patolog&iacute;a e Inmunohistoqu&iacute;mica de Chihuahua, S.C. Chihuahua, Chihuahua</p>

Keywords:

Pleural Effusion, Biopsy, Needle, Cancer

Abstract

In this letter to the editor it is discussed the use of Tru-cut needle in pleural biopsy and its profitability for the diagnosis of mesothelioma; it is exposed as well its usefulness, having the appropriate training, to obtain guiding results in obese people.

Downloads

Download data is not yet available.

Author Biographies

  • René Agustín Flores-Franco, <p>Instituto Mexicano del Seguro Social, Hospital General Regional de Zona No. 1, Departamento de Medicina Interna. Chihuahua, Chihuahua</p>

    Neumólogo e internista con ocupación asistencial

  • Ernesto Ramos-Martínez, <p>Patolog&iacute;a e Inmunohistoqu&iacute;mica de Chihuahua, S.C. Chihuahua, Chihuahua</p>

    Patólogo clinico miembro activo de la Academia Nacional de Médicina

References

Valdez-López HG, Cano-Rodríguez AI, Montemayor-Chapa M, Castillo Sánchez JF. Rentabilidad diagnóstica de la biopsia pleural cerrada: Tru-cut frente a Cope. Rev Med Inst Mex Seguro Soc. 2018;56(1):12-7.

 

Flores-Franco RA, Ramos-Martínez E, Luévano-Flores E, Fierro-Murga R, Barriga-Acevedo R, Martínez-Tapia ME et al. Malignant mesothelioma trends in Chihuahua, Mexico. Salud Publica Mex. 2014;56(4):315-6.

Downloads

Published

2019-05-09

Issue

Vol. 57 No. 1 (2019): January-February

Section

Letter to the Editor

License

Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.